Premium
BORTEZOMIB PREVENTS DEVELOPMENT OF CYTARABINE RESISTANCE IN A MANTLE CELL LYMPHOMA IN VITRO MODEL
Author(s) -
Freiburghaus C.,
Kuci Emruli V.,
Johansson A.,
Olsson R.,
Ek F.,
Geisler C.H.,
Jerkeman M.,
Ek S.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_174
Subject(s) - cytarabine , clofarabine , cancer research , mantle cell lymphoma , bortezomib , pharmacology , fludarabine , gemcitabine , biology , medicine , immunology , leukemia , lymphoma , chemotherapy , cyclophosphamide , multiple myeloma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom